Rapamycin enhances adenovirus-mediated cancer imaging and therapy in pre-immunized murine hosts.

PloS one

Volumn 8, Issue 9, 2013, Pages

  Jiang, Ziyue Karen ^a   Johnson, Mai ^b   Moughon, Diana L ^b   Kuo, Jennifer ^b   Sato, Makoto ^b   Wu, Lily ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN; THYMIDINE KINASE;

ADAPTIVE IMMUNITY; ADENOVIRIDAE; ANIMAL; DRUG EFFECTS; GENE THERAPY; GENE VECTOR; GENETICS; IMMUNIZATION; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; MALE; MOLECULAR IMAGING; MOUSE; PROCEDURES; PROSTATIC NEOPLASMS; SAFETY; TRANSGENE; TUMOR CELL LINE;

ADAPTIVE IMMUNITY; ADENOVIRIDAE; ANIMALS; CELL LINE, TUMOR; GANCICLOVIR; GENETIC THERAPY; GENETIC VECTORS; IMMUNITY, INNATE; IMMUNIZATION; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; MALE; MICE; MOLECULAR IMAGING; PROSTATIC NEOPLASMS; SAFETY; SIROLIMUS; THYMIDINE KINASE; TRANSGENES;

EID: 84897920174     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073650     Document Type: Article

References (0)